Related by context. All words. (Click for frequent words.) 63 Tomas Puusepp 59 Per Olof Wallström 58 Ulrich Dauer CEO 58 Elisabeth Lindner CEO 57 Marc Oczachowski 57 Martin Nicklasson CEO 56 Dominique Costantini 56 Dr. Fahar Merchant 56 haematological cancers 56 immatics 56 Harry Palmin President 55 Mr. Rosconi 55 JenaValve 55 phase IIb trial 55 Martin Nicklasson 55 CytoFabTM 54 Karo Bio 54 Manja Bouman CEO 54 Biolipox 54 Mr. Fater 54 Revotar 54 Mr. Williger 53 AEterna 53 Michael H. Tardugno 53 deforolimus 53 André Michel Ballester 53 PSMA ADC 53 Hugues de Bantel 53 MDxHealth 53 Alton Boynton 52 EndoTAG TM -1 52 Insegia 52 Mr. Kriegsman 52 Mark A. Sirgo 52 Tripep 52 rALLy clinical trial 52 Daniel Vasella Chairman 52 SNT MC# 52 Anthony Giovinazzo 52 Rolland Yves Mauvernay 52 EchoCRT 52 ELACYT 52 Neogenix 52 ThromboGenics commenting 52 Patrik De Haes 52 Loïc Maurel MD 51 Michele Garufi Chairman 51 PregLem 51 Daniel Junius 51 WILEX 51 Elocalcitol 51 Evoltra TM 51 Gregory D. Casciaro 51 Photocure 51 Solasia 51 PRESEPT Study 51 TroVax ® 51 SUCCEED trial 51 NeuVax 51 Dr. Aiping Young 51 GammaCan 51 BioGeneriX 51 GRN# 51 PRESEPT study 51 WILEX AG 51 antiangiogenic therapy 51 lumiliximab 51 Werner Cautreels 51 HalcyGen 51 Safi Bahcall Ph.D. 51 CA9 SCAN 51 FluoroPharma 51 Mr. Frank Menzler 51 ARIKACE ™ 51 Adrian Hobden Ph.D. 50 ularitide 50 Timo Veromaa 50 Dr. Pingpank 50 AMPK activators 50 oncolytics 50 Celmed 50 IMA# 50 RhuDex ® 50 MET inhibitor 50 Philippe Calais 50 Serdolect ® 50 eritoran 50 p# inhibitor 50 Zavesca r 50 PDE# inhibitors 50 clinical pharmacology studies 50 QTinno TM 50 PROCHYMAL 50 BIOCEUTICALS 50 Ron Bentsur 50 zanolimumab 50 VITAL Trial 50 t2cure GmbH 50 TEMSO 50 Phase #b/#a clinical 50 Æterna Zentaris 50 Dr. Yatscoff 50 stated Dominique Costantini 50 Jean Luc Bélingard 50 Pseudomonas aeruginosa infections 50 ERYtech Pharma 50 indibulin 50 EndoTAGTM 1 50 Tracleer r 50 Oncotype DX Recurrence Score 50 Phase Ib II 50 Nanobody 50 Steven R. Deitcher 50 Georges Gemayel 50 Axentis Pharma 50 Toraymyxin TM 50 Hans Joachim Lohrisch 50 Abiraterone acetate 50 thetreatment 50 Neil K. Warma 50 SNT-MC#/idebenone 50 Solorel TM 50 Vincent Mutel CEO 49 Proellex TM 49 Innate Pharma 49 trastuzumab DM1 49 Damian Marron 49 Mr. Feldenkreis 49 recurrent glioblastoma 49 CR# vcMMAE 49 Dr. Urnovitz 49 OMAPRO 49 DeveloGen 49 EGRIFTA ™ 49 aerosolized surfactant 49 NP2 Enkephalin 49 BioNumerik 49 BrachySil TM 49 Dr. Henrich Guntermann 49 Clinuvel 49 Dr. Michelle Berrey 49 ICON7 49 Voraxaze ™ 49 IIa trial 49 Ele Ferrannini 49 phase IIa clinical 49 Phase IIIb clinical 49 Allovectin 7 ® 49 Spiro Rombotis President 49 CRD5 49 Elisabeth Lindner 49 Nanobiotix 49 glucokinase activator 49 ThromboGenics commented 49 Doliveux 49 Phase #b/#a 49 NicOx commented 49 Removab 49 Tovaxin TM 49 Dr. Fehlings 49 Peter Riehl Stellar 49 Omthera 49 Telatinib 49 Dr. Horst Zerbe 49 Kirsten Drejer 49 subcutaneous immunoglobulin 49 cystinosis patients 49 Ophena 49 pharmacokinetic PK study 49 Dr. Eliaz 49 preclinically 49 MediGene focuses 49 Phase III metastatic melanoma 49 eprotirome 49 Mr. Owusu Akyaw 49 Sudhir Agrawal D.Phil 49 CONBRIZA 49 Oglemilast 49 Jean Luc Belingard 49 Garo H. 49 Altastaph 49 BioMatrix TM 49 Onno van de Stolpe 49 Sopherion 48 AA Amyloidosis 48 Can Fite 48 PROSTVAC ® 48 forodesine 48 CureTech 48 G#DT 48 HDL Selective Delipidation 48 MYTHOS trial 48 Dan Passeri 48 inhaled AAT 48 Lu AA# 48 Arno Therapeutics 48 ImmunoVEX HSV2 48 Therabel 48 drug eluting stent DES 48 ABSORB trial 48 Philippe Archinard 48 Mark HN Corrigan 48 SMT C# 48 Loramyc ® 48 ganaxolone 48 tesmilifene 48 NOXXON 48 Dino Dina 48 refractory CLL 48 Potelligent Technology 48 phase IIb clinical 48 Arpida Ltd. 48 Afatinib 48 Mr. Jassawalla 48 Anker MD Ph.D. 48 ThGRF 48 novel therapeutic antibodies 48 Dr. Grodman 48 CCR9 antagonist 48 Mr. Keltjens 48 CTAP# Capsules 48 Yves Rosconi 48 Stragen 48 Mr. Contesse 48 multicenter trials 48 HGS# 48 oral ridaforolimus 48 adrenergic regulation 48 AERx iDMS 48 Christopher Anzalone Arrowhead 48 Egrifta 48 Loramyc TM 48 James Manuso 48 von Rickenbach 48 radiographic outcomes 48 MVA BN 48 Virulizin R 48 HIV coinfected 48 YONDELIS 48 Viprinex TM 48 4SC AG 48 Mr. Luc Mainville 48 Lonnie Moulder 48 ALTANA Pharma 48 Iris Loew Friedrich 48 David Aviezer 48 Barry D. Quart 48 pivotal bioequivalence 48 Dr. Von Hoff 48 BB BIOTECH 48 Phase Ib study 48 clevidipine 48 HuMax EGFr 48 Carl A. Pelzel 48 Tony Milici 48 Phase IIb clinical trials 48 Jean Claude Tardif 48 GFT# 48 Loramyc 48 JP-#/fipamezole 47 interferon beta therapy 47 Anavex #-# 47 Dr. Ayalew Tefferi 47 masitinib 47 Mr. Mordock 47 velafermin 47 Tocosol Paclitaxel 47 romazarit 47 Canvaxin 47 mTOR inhibition 47 alvespimycin 47 Hedgehog antagonist 47 initiate Phase 2b 47 ACOMPLIA R 47 Advitech 47 AZD# TC 47 Bergenstal 47 budesonide MMX Phase III 47 James Sapirstein 47 EnVivo 47 Syntonix 47 NeuroVax 47 Santhera 47 Urocidin 47 commented Alexis Borisy 47 Dr. Randall Yatscoff 47 Mihael Polymeropoulos MD 47 Kiadis Pharma 47 relapsed MCL 47 Lars Stugemo 47 Magnus Nilsson CEO 47 ATL/TV# 47 Shai N. Gozani 47 immunosuppressant therapies 47 Goran Ando 47 Sol J. Barer 47 OHR/AVR# 47 OnDose 47 renin inhibition 47 Aurora kinase inhibitor 47 Butchofsky 47 Lixivaptan 47 Elafin 47 vidofludimus 47 Auxilium Pharma 47 MAGE A3 ASCI 47 Dr. Stylli 47 initiate Phase IIb 47 midstage trials 47 SCENESSE ® 47 David Spaight 47 PRECISE trial 47 EndoTAG TM 47 initiated Phase Ib 47 ADVANCE PD 47 Dr. Arndt Schottelius 47 oral salmon calcitonin 47 huC# DM4 47 Ronan O'Caoimh CEO 47 EDAP TMS 47 Remi Barbier 47 peritoneal carcinomatosis 47 riociguat 47 ADAGIO study 47 DSMB recommendation 47 RSD# oral 47 Gamida Cell 47 isavuconazole 47 Virulizin ® 47 Bezielle 47 PRESEPT 47 Juergen Engel Ph.D. 47 STRIDE PD 47 multicenter clinical trials 47 doxorubicin docetaxel 47 Demopulos 47 Evoltra 47 StemEx R 47 J. Mazzo Ph.D. 47 Tod Woolf Ph.D. 47 OGeS 47 elacytarabine 47 Angioblast 47 plasma kallikrein inhibitor 47 Carotid endarterectomy 47 HuCAL antibodies 47 Cinquil 47 SinuNase ™ 47 atacicept 47 lenalidomide dexamethasone 47 Kevetrin TM 47 IRX 2 47 incyclinide 47 Desmoteplase 47 Dr. Scangos 46 DELEX 46 Dan Passeri Curis 46 NASDAQ IPXL today 46 OncoVEX 46 HuMax CD4 46 rALLy trial 46 Fibrocell 46 IIa trials 46 MyVax ® 46 Viramidine 46 ESBATech 46 Pimavanserin 46 Phase lll 46 Cipralex ® 46 Jeffrey M. Ostrove 46 rindopepimut 46 eniluracil 46 Sijmen de Vries 46 eTag assays 46 Src inhibitors 46 Zelnorm Zelmac 46 CaPre TM 46 BNC# 46 LHRH antagonists 46 BEXXAR 46 inflatable penile prosthesis 46 UVIDEM 46 B. Lynne Parshall 46 Drakeman 46 Tracleer R 46 photoprotective drug 46 ProSavin 46 OvaRex R 46 apricitabine 46 initiate Phase 1b 46 Kamada AAT 46 Aplidin 46 inecalcitol 46 Haim Aviv 46 Nicholas Borys 46 Xerecept 46 Igor Gonda Ph.D. 46 IgG1 antibodies 46 Harold Van Wart 46 mg/m2 cohort 46 Jeffrey H. Buchalter 46 Synt em 46 Christian Itin 46 USL# 46 oxaliplatin Eloxatin 46 Mr. Tardugno 46 HQK 46 pediatric acute lymphoblastic 46 samalizumab 46 Silodosin 46 successfully commercialize Iluvien 46 OvaRex 46 nalbuphine ER 46 ESTRASORB 46 durable remissions 46 microdose 46 PHX# 46 Zami Aberman Chairman 46 enzastaurin 46 Dr. Gozani 46 Howard H. Pien 46 Cethrin 46 Phase III ADT 46 Igeneon 46 RhuDex TM 46 Adenuric R 46 IPL# 46 CEO Nadav Kidron 46 Prolor 46 BRAF inhibitors 46 Medgenics 46 Tumor shrinkage 46 RPL# 46 Greg Wujek 46 AIM HIGH 46 QVAR 46 Cimzia TM 46 Robert L. Chioini 46 PyratineXR 46 Christopher J. Schaber 46 Mr. Weidong Yin 46 lomitapide 46 Anthony DiTonno President 46 Allovectin 7 46 Dr. Sackner 46 BIM #A# 46 omacetaxine mepesuccinate 46 ThromboGenics 46 Trophos 46 Michel Morre DVM 46 FOLOTYN ® 46 Memryte 46 Pedro Lichtinger 46 Dr. Tashkin 46 Triapine R 46 Diamyd ® 46 Firazyr 46 CAPHOSOL 46 triphendiol 46 CRMD# 46 Dr. McHutchison 46 Hemopurifier ® 45 Inflazyme 45 Tesmilifene 45 LB# [003] 45 NVA# 45 budesonide foam 45 INTEGRILIN 45 RLY# 45 PNT# 45 GENASIS trial 45 Hedgehog Pathway Inhibitor 45 Cytheris 45 Medidur FA 45 Arikace 45 Kosan dependence 45 Germany FSE SCH 45 Dr. Anil Diwan 45 isoform selective 45 Novosom 45 CAMPATH 45 CURE AF 45 outlicensing 45 Aegera 45 Panzem R NCD 45 collaborator Genentech 45 Phase #/#a clinical 45 dose escalation Phase 45 Bicifadine 45 Michael Fonstein Ph.D. 45 sitaxsentan 45 PROSTVAC TM 45 Trofex 45 Erlen 45 IVTA 45 Emezine 45 immunomodulation 45 Jacob Inbar 45 Ruiz Comas 45 RH1 45 H. Willard Flamel 45 Dr. Sosne 45 Cutanea 45 ulimorelin 45 debulking surgery 45 taxane therapy 45 Multiple Ascending Dose 45 apricitabine ATC 45 Laheru 45 ViroStatics 45 leading oral taxane 45 NeuroSolutions 45 Dynogen 45 Protelos 45 tubulin inhibitor 45 trastuzumab emtansine T DM1 45 Alvesco R 45 Dr. Shrotriya 45 SYGNIS 45 systemic RNAi 45 Hawes Fairley 45 KIACTA ™ 45 REMINYL ® 45 Randomized clinical trials 45 O PPDS 45 teriflunomide 45 Azilect ® 45 Flutiform TM 45 Rosen ViroPharma 45 Uvidem 45 Svein Mathisen CEO 45 CRLX# 45 TOPIGEN 45 Dr. Maraganore 45 Keith Katkin AVANIR 45 J. Schaber PhD 45 PathFinderTG 45 Daniel Passeri Curis 45 PSN# [001] 45 Friedhelm Blobel Ph.D. 45 cortical stimulation 45 EDEMA3 trial 45 GMX# 45 Dr. Isa Odidi 45 aptamer therapeutics 45 Thiovir 45 Ketotransdel 45 cannabinor 45 Lisa N. Drakeman 45 Mr. Yves Rosconi 45 Phase 1b trial 45 phase IIa 45 SWX SPPN 45 Option IVC Filter 45 Klaus Schollmeier 45 Vitaxin 45 mCRPC 45 Jal S. Jassawalla 45 zotarolimus 45 C1 INH 45 BLA filing 45 Exherin TM 45 Dr. Wayne Danter 45 Yves Rosconi President 45 H. pylori eradication 45 Kevetrin ™ 45 follicular adenoma 45 AeroLEF TM 45 Jean Luc Bélingard Chairman 45 TACI Ig 45 MAA submission 45 inhibit metastasis 45 PROactive study 45 bevasiranib 45 macitentan 45 TKM PLK1 45 clonidine hydrochloride 45 GSK '# 45 vismodegib 45 Mr. Armando Anido 45 Hsp# inhibition 45 Endeavor DES 45 Peer Schatz 45 DermaVir Patch 45 AVAX 45 Joshua Boger Ph.D. 45 RIO Lipids 45 NV1FGF 44 Don Kiepert President 44 vosaroxin 44 Bioaccelerate compounds under 44 LibiGel Phase III 44 QuadraSphere 44 GED aPC 44 PhytoMedical 44 Hedgehog inhibitor 44 HCD# [002] 44 ZOLINZA 44 rhFVIIa 44 everolimus eluting stents 44 Bioral Amphotericin B 44 zileuton IV 44 JAK2 inhibitor 44 Kleanthis G. Xanthopoulos Ph.D. 44 Symadex 44 Arranon 44 TASQ 44 BioRexis 44 rasagiline tablets 44 Personalized Immunotherapy 44 Steven B. Ratoff 44 DPX Survivac 44 Chang Ahn Rexahn 44 Telbivudine 44 PAION 44 Dr. Marlies Sproll 44 refractory colorectal cancer 44 PRTX 44 prostatic tissue 44 Robert L. Bratzler 44 Robert Motzer MD 44 bicifadine 44 Phase IIB clinical 44 elotuzumab 44 oral FTY# 44 oral rivaroxaban 44 Zemplar Capsules 44 lesional 44 Murray Tekmira 44 Dr. Bassam Damaj 44 lixivaptan 44 Dr. Nikolaus Schweickart 44 SYMMETRY trial 44 Genfit 44 immune modulating 44 darunavir r 44 JAK#/JAK# inhibitor CYT# 44 Carl Spana Ph.D. 44 RhuDex 44 Tarsa oral calcitonin 44 Arginox 44 PEP# [003] 44 generic enoxaparin 44 EP #R 44 OvaRex ® MAb 44 Nicole Onetto MD 44 Blum Cytokinetics 44 BioInvent commented 44 brivaracetam 44 imatinib therapy 44 Guy Nissenson 44 symptomatic paroxysmal AF 44 Francois Nader 44 Addrenex 44 Paul Laikind 44 NEVO ™ 44 Spiegelmer ® 44 Dr. Seizinger 44 IMC #B 44 Epidemiologist Renaud Piarroux 44 viral kinetics 44 Nick Leschly 44 rxRNA 44 FlutiformTM 44 Zami Aberman Pluristem 44 Donald L. Drakeman 44 subsidiaries visit http:/www.apricusbio.com 44 BioSyent TSX VENTURE 44 Mr. Bentsur 44 CIMZIA ™ 44 Angiox ® 44 Phase 2a trial 44 SonoLysis 44 hematological indications 44 Ms. Katen 44 faropenem 44 J. Donald deBethizy 44 Dr. Raafat Fahim 44 Pyridorin 44 Lorianne Masuoka MD 44 aplindore 44 fidaxomicin Phase 44 confirmatory clinical 44 Stimuvax R 44 pradefovir 44 Visit www.BASInc.com 44 SCOLR Pharma 44 Adventrx 44 Mr. Sidibé 44 Loretta M. Itri 44 DP b# 44 Jean Paul Clozel 44 Dr. Tsengas 44 ASSERT trial 44 ACZ# 44 Glypromate 44 XP #L 44 Phase 1a clinical 44 Phase IIb trials 44 dose cohort 44 LEVADEX ™ 44 relapsed ALL 44 Neuradiab 44 oral methylnaltrexone 44 Fereydoun Firouz 44 GAP #B# 44 epigenetic therapies 44 MGMT methylation 44 AZILECT ® 44 heterozygous FH 44 CEO Harrie Noy 44 Aflibercept 44 EDEMA3 44 Zavesca ® 44 Akt inhibitor 44 Rik J Deitsch 44 rolapitant 44 Biotie 44 Aviptadil 44 Alzhemed TM 44 Maximum Tolerated Dose 44 ATL# [001] 44 Civacir 44 dose escalation phase 44 KROMI 44 Thorough QT TQT 44 Frobell 44 vascular disrupting agent 44 midstage clinical 44 Quay MD Ph.D. 44 Reverset 44 Study #CL# 44 Lung Rx 44 ACTEMRA TM 44 gallium containing 44 octreotide implant 44 Steve Worland Ph.D. 44 Dr. Francesco Bellini 44 small molecule tyrosine 44 pharmacokinetic equivalence 44 ongoing Phase IIIb 44 tramiprosate Alzhemed TM 43 TAXUS stents 43 QTinno 43 oral PTH 43 Numoda 43 Mr. Pierre Laurin 43 Dr. Damaj 43 Cand5 43 recombinant antithrombin product 43 Urocortin 2 43 cytokine refractory 43 trastuzumab DM1 T DM1 43 CUSTOM III 43 Troxatyl 43 Zevalin consolidation 43 Genz # 43 bavituximab monotherapy trial 43 FR# announces 43 APOPTONE 43 Xcytrin R 43 4SC commented 43 Vaughn M. Kailian 43 oral picoplatin 43 cMET 43 Squalamine 43 EnzymeRx 43 Rezular 43 obatoclax 43 Drew Fromkin President 43 Randomized trials 43 randomized Phase 2b 43 Aerovant 43 TRISENOX 43 Etubics 43 UPLYSO 43 inhaled liposomal ciprofloxacin 43 Phase III HEAT 43 Prestara 43 EGFR mutation status 43 tramiprosate ALZHEMED TM 43 Mr. Bassoul 43 Essential Medicines List 43 Spheramine 43 Isolagen Process 43 Ostabolin C 43 fibrotic disease 43 Neuropharma 43 Protalex 43 Dr. Fonstein 43 Gilles Gagnon 43 Renaud Beauchesne 43 CINTREDEKIN BESUDOTOX 43 HuLuc# 43 SCENESSE 43 thymidylate synthase TS 43 Dacogen injection 43 GHIS 43 Asentar 43 kinase inhibition 43 cediranib 43 JAK inhibitor 43 Mark Pykett 43 ozarelix 43 canakinumab 43 GLP toxicology studies 43 ONCONASE R 43 IgG1 antibody 43 Sayan Navaratnam 43 optimal dosing regimens 43 punctal plug delivery 43 favorable pharmacokinetic profile 43 Dr. Cauwenbergh 43 VIDAZA ® 43 Pascal Pfister 43 mediated inhibition 43 BEMA TM Fentanyl 43 renin inhibition promising 43 partner Lux Biosciences 43 TRIST study 43 EVIZON 43 CCX# B 43 Teplizumab 43 TRO# 43 JIT Solaire 43 A3 adenosine receptor 43 Sensipar 43 Vernakalant 43 Corautus 43 Cascade LifeSciences 43 radezolid 43 mGluR5 inhibition 43 Joseph K. Belanoff 43 OMNARIS HFA 43 PRIMO CABG 43 Aquinox 43 Bionutrics 43 Sydbank analyst Rune Dahl 43 Garnet Biotherapeutics 43 male circumcision reduces 43 HuCAL 43 selective S#P# receptor agonist 43 BioXell 43 XmAb# 43 DACH platinum 43 MAXY alpha 43 bardoxolone 43 THALOMID 43 VTE prevention 43 Evoltra ® 43 oral treprostinil 43 Bill Forbes Pharm.D 43 RIGScan CR 43 BeneFIX 43 Antony Koblish President 43 BCR ABL inhibitors 43 Michael V. Novinski 43 Dr. Laikind 43 Mr. Melnuk 43 Gleevec resistant 43 TASKi2 43 Ventavis ® 43 Mr. Godevais 43 registrational 43 REMUNE R 43 MAXY VII 43 thorium utilization 43 Dr. Blobel 43 Panzem 43 Cogane 43 XERECEPT R 43 novel oral anticoagulant 43 Technosphere Insulin 43 ARIKACE 43 Anat Cohen Dayag 42 ENMD # 42 injectable formulations 42 Newron 42 Ph.D. Targacept 42 ImmunoCellular Therapeutics 42 TBC# 42 Cortria 42 ORMD 42 Glenn A. Oclassen 42 chimeric monoclonal antibody 42 NEBIDO 42 PEG SN# 42 pexiganan 42 Vincent Milano ViroPharma 42 SLx 42 NASDAQ DYAX 42 ThermoDox ® clinical 42 prognostic indicators 42 Acando 42 Plicera 42 maximally tolerated 42 Relypsa 42 XL# SAR# 42 elvucitabine 42 modified REGENESIS Phase IIb 42 Dr. Marc Gillinov 42 APEX AMI trial 42 plasminogen activators 42 Ceflatonin 42 Zingo TM 42 Subgroup analysis 42 Fc fusion protein 42 Limited SGX H#.SI 42 sargramostim 42 LibiGel testosterone gel 42 talabostat 42 CDP# 42 MERLIN TIMI 42 CLL8 42 aleglitazar 42 my3KG 42 EGRIFTA TM 42 retaspimycin 42 oral RELISTOR 42 Lipid lowering 42 IIa clinical trial 42 TriGrid ™ 42 Archexin 42 Oracea TM 42 ponatinib 42 DDP# 42 phase IIb 42 Dr. Fombonne 42 Dr. Zelenetz 42 novel VDA molecule 42 Yakatan 42 Dr. Gussak 42 SpHb monitoring 42 Miravant 42 EGS# 42 Fibrillex TM 42 Nasdaq CYCC Nasdaq CYCCP 42 L BLP# 42 Phase IIb III 42 SinuNase 42 Pharmacokinetic studies 42 etquot 42 Gord Froehlich President 42 ostarine 42 TransVax tm 42 otelixizumab 42 LidoPAIN SP 42 Luc Tanguay 42 Rebif ® 42 Dendreon Provenge 42 novel trazodone formulation 42 PANVAC VF 42 John Maraganore Ph.D. 42 torsemide ER 42 Dose escalation 42 Potiga 42 Metallurgical testwork 42 Intergroup Exemestane Study 42 OvPlex ™ 42 tiapamil 42 mutated K ras 42 Maraganore 42 CIP TRAMADOL ER 42 COSIRA trial 42 HCV protease inhibitors 42 oral taxane 42 Dr Chiplin 42 MIST II 42 Ms. Lurker 42 PDE4 inhibitor 42 pharmacological chaperone 42 gastric stasis 42 Dr. Rahul Singhvi 42 Inc. NASDAQ ICGN 42 Anticalin R 42 TLR antagonists 42 vivo potency 42 ruxolitinib 42 cardioprotective effects 42 GRAVITAS trial 42 Phase IIB 42 registrational trial 42 JAK inhibitors 42 Christian Reinaudo 42 TOCOSOL Paclitaxel 42 G2 BioChem 42 IND submission 42 ARISE Phase III 42 Cinryze ™ 42 PINKSHEETS TCHH 42 Thorough QT 42 Mark Leuchtenberger 42 Prof. Krainer 42 BioAlliance 42 CRACM 42 Phospha E 42 Modrenal 42 INTEGRILIN R eptifibatide Injection 42 opioid bowel dysfunction